ISSN:

Journal Home

Journal Guideline

Expert Opinion on Orphan Drugs Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Orphan Drugs is a journal indexed in SJR in Health Policy and Pharmacology (medical) with an H index of 29. It has a price of 1800 €. It has an SJR impact factor of 0,286 and it has a best quartile of Q2. It has an SJR impact factor of 0,286.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2) Health Policy (Q3) Pharmacology (medical) (Q3)

Price

1800 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,286

SJR Impact factor

29

H Index

5

Total Docs (Last Year)

39

Total Docs (3 years)

349

Total Refs

34

Total Cites (3 years)

36

Citable Docs (3 years)

1.09

Cites/Doc (2 years)

69.8

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Digital Health Q2
Chronic Illness Q2
International Journal for Quality in Health Care Q2
International Journal of Technology Assessment in Health Care Q2
Journal of Medical Screening Q2

Compare this journals